Buy Akero Therapeutics Inc Stock | AKRO Stock Price & Latest News | Public
AKRO

Akero Therapeutics Inc

$0.00 (0.00%)Today

    About AKRO

    Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 20...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.21
    -0.42
    -0.63
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.60

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,01B
    Volume4,76k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$41.16
    1 Year Low$10.78
    Open$29.24
    High$29.32
    Low$28.23

    Buy any stock with any amount of money.

    Download the App
    Download the app